Cited by 598Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016

Open access
Cerdá, Magdalena, Mauro, Christine, Hamilton, Ava, Levy, Natalie S., Santaella-Tenorio, Julián, Hasin, Deborah, Wall, Melanie M., Keyes, Katherine M. +1 more·2020·JAMA Psychiatry

Abstract

Importance: Little is known about changes in marijuana use and cannabis use disorder (CUD) after recreational marijuana legalization (RML). Objectives: To examine the associations between RML enactment and changes in marijuana use, frequent use, and CUD in the United States from 2008 to 2016. Design, Setting, and Participants: This survey study used repeated cross-sectional survey data from the National Survey on Drug Use and Health (2008-2016) conducted in the United States among participants in the age groups of 12 to 17, 18 to 25, and 26 years or older. Interventions: Multilevel logistic regression models were fit to obtain estimates of before-vs-after changes in marijuana use among respondents in states enacting RML compared to changes in other states. Main Outcomes and Measures: Self-reported past-month marijuana use, past-month frequent marijuana use, past-month frequent use among past-month users, past-year CUD, and past-year CUD among past-year users. Results: The study included 505 796 respondents consisting of 51.51% females and 77.24% participants 26 years or older. Among the total, 65.43% were white, 11.90% black, 15.36% Hispanic, and 7.31% of other race/ethnicity. Among respondents aged 12 to 17 years, past-year CUD increased from 2.18% to 2.72% after RML enactment, a 25% higher increase than that for the same age group in states that did not enact RML (odds ratio [OR], 1.25; 95% CI, 1.01-1.55). Among past-year marijuana users in this age group, CUD increased from 22.80% to 27.20% (OR, 1.27; 95% CI, 1.01-1.59). Unmeasured confounders would need to be more prevalent in RML states and increase the risk of cannabis use by 1.08 to 1.11 times to explain observed results, indicating results that are sensitive to omitted variables. No associations were found among the respondents aged 18 to 25 years. Among respondents 26 years or older, past-month marijuana use after RML enactment increased from 5.65% to 7.10% (OR, 1.28; 95% CI, 1.16-1.40), past-month frequent use from 2.13% to 2.62% (OR, 1.24; 95% CI, 1.08-1.41), and past-year CUD from 0.90% to 1.23% (OR, 1.36; 95% CI, 1.08-1.71); these results were more robust to unmeasured confounding. Among marijuana users in this age group, past-month frequent marijuana use and past-year CUD did not increase after RML enactment. Conclusions and Relevance: This study's findings suggest that although marijuana legalization advanced social justice goals, the small post-RML increase in risk for CUD among respondents aged 12 to 17 years and increased frequent use and CUD among adults 26 years or older in this study are a potential public health concern. To undertake prevention efforts, further studies are warranted to assess how these increases occur and to identify subpopulations that may be especially vulnerable.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamapsychiatry.2019.3254

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tobacco and alcohol companies are buying into the cannabis industry.

    “Tobacco and alcohol companies are buying into the industry.”

    From Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis? (2020) · cites this paper as [3]

    The Discussion addresses changes in marijuana use after legalization, and the Limitations mention future study after commercialization. Neither section says that tobacco or alcohol companies are buying into the cannabis industry. Searches for company investment, acquisitions, and commercialization found no passage addressing that claim. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 42

  1. Thomson WM, Poulton R, Broadbent JM, et al. Cannabis smoking and periodontal disease among young adults. JAMA. 2008;299(5):525-531. doi:10. 1001/jama.299.5.525 · DOI
  2. Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35(1):42-47. doi:10.1183/09031936.00065009 · DOI
  3. Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction. 2000;95(11):1621-1630. doi:10.1046/ j.1360-0443.2000.951116213.x · DOI
  4. Fergusson DM, Boden JM, Horwood LJ. Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study. Soc Psychiatry Psychiatr Epidemiol. 2015;50(9):1317-1326. doi:10.1007/s00127-015-1070-x · DOI
  5. Cerdá M, Moffitt TE, Meier MH, et al. Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: a longitudinal cohort study. Clin Psychol Sci. 2016;4(6):1028-1046. doi:10.1177/ 2167702616630958 · DOI
  6. Li MC, Brady JE, DiMaggio CJ, Lusardi AR, Tzong KY, Li G. Marijuana use and motor vehicle crashes. Epidemiol Rev. 2012;34(1):65-72. doi:10.1093/ epirev/mxr017 · DOI
  7. Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 2015;110(1): 19-35. doi:10.1111/add.12703 · DOI
  8. Sarvet AL, Wall MM, Fink DS, et al. Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis. Addiction. 2018;113(6):1003-1016. doi:10.1111/add.14136 · DOI
  9. Anderson D, Hansen B, Rees D. Medical marijuana laws, traffic fatalities, and alcohol consumption. J Law Econ. 2013;56(2):333-369. doi:10.1086/668812 · DOI
  10. Wen H, Hockenberry JM, Cummings JR. The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. J Health Econ. 2015;42:64-80. doi:10. 1016/j.jhealeco.2015.03.007 · DOI
  11. Harper S, Strumpf EC, Kaufman JS. Do medical marijuana laws increase marijuana use? replication study and extension. Ann Epidemiol. 2012;22(3): 207-212. doi:10.1016/j.annepidem.2011.12.002 · DOI
  12. Schuermeyer J, Salomonsen-Sautel S, Price RK, et al. Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-11. Drug Alcohol Depend. 2014;140:145-155. doi:10.1016/ j.drugalcdep.2014.04.016 · DOI
  13. Hasin DS, Sarvet AL, Cerdá M, et al. US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013. JAMA Psychiatry. 2017;74(6):579-588. doi:10.1001/ jamapsychiatry.2017.0724 · DOI
  14. Martins SS, Mauro CM, Santaella-Tenorio J, et al. State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population. Drug Alcohol Depend. 2016;169:26-32. doi:10.1016/j.drugalcdep.2016.10.004 · DOI
  15. Mauro CM, Newswanger P, Santaella-Tenorio J, Mauro PM, Carliner H, Martins SS. Impact of medical marijuana laws on state-level marijuana use by age and gender, 2004-2013. Prev Sci. 2019;20 (2):205-214. doi:10.1007/s11121-017-0848-3 · DOI
  16. Pacula RL, Kilmer B, Wagenaar AC, Chaloupka FJ, Caulkins JP. Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am J Public Health. 2014;104(6):1021-1028. doi:10. 2105/AJPH.2013.301766 · DOI
  17. Hasin DS, Wall M, Keyes KM, et al. Medical mari- juana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys. Lancet Psychiatry. 2015;2(7): 601-608. doi:10.1016/S2215-0366(15)00217-5 · DOI
  18. Hall W, Weier M. Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clin Pharmacol Ther. 2015;97(6):607-615. doi:10.1002/cpt.110 · DOI
  19. Khatapoush S, Hallfors D. "Sending the wrong message": did medical marijuana legalization in California change attitudes about and use of marijuana? J Drug Issues. 2004;34:751-770. doi:10.1177/002204260403400402 · DOI
  20. Mason WA, Hanson K, Fleming CB, Ringle JL, Haggerty KP. Washington State recreational marijuana legalization: parent and adolescent perceptions, knowledge, and discussions in a sample of low-income families. Subst Use Misuse. 2015;50(5):541-545. doi:10.3109/10826084.2014.952447 · DOI
  21. Cerdá M, Wall M, Feng T, et al. Association of state recreational marijuana laws with adolescent marijuana use. JAMA Pediatr. 2017;171(2):142-149. doi:10.1001/jamapediatrics.2016.3624 · DOI
  22. Miller AM, Rosenman R, Cowan BW. Recreational marijuana legalization and college student use: early evidence. SSM Popul Health. 2017;3:649-657. doi:10.1016/j.ssmph.2017.08.001 · DOI
  23. Anderson DM, Hansen B, Rees DI, Sabia JJ. Association of marijuana laws with teen marijuana use: new estimates from the youth risk behavior surveys. JAMA Pediatr. 2019;173(9):879-881. doi:10.1001/jamapediatrics.2019.1720 · DOI
  24. Pacula RL, Hunt P, Boustead A. Words can be deceiving: a review of variation among legally effective medical marijuana laws in the United States. J Drug Policy Anal. 2014;7(1):1-19. doi:10.1515/jdpa-2014-0001 · DOI
  25. Kim JH, Santaella-Tenorio J, Mauro C, et al. State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers. Am J Public Health. 2016;106(11):2032-2037. doi:10.2105/AJPH.2016.303426 · DOI
  26. Keyes KM, Wall M, Cerdá M, et al. How does state marijuana policy affect US youth? medical marijuana laws, marijuana use and perceived harmfulness: 1991-2014. Addiction. 2016;111(12): 2187-2195. doi:10.1111/add.13523 · DOI
  27. de Boor C. A Practical Guide to Splines. New York, NY: Springer-Verlag; 1978. doi:10.1007/978-1-4612- 6333-3 · DOI
  28. Little R. To model or not to model? competing modes of inference for finite population sampling. J Am Stat Assoc. 2004;99:546-556. doi:10.1198/ 016214504000000467 · DOI
  29. Segura LE, Mauro CM, Levy NS, et al. Association of US medical marijuana laws with nonmedical prescription opioid use and prescription opioid use disorder. JAMA Netw Open. 2019;2(7):e197216. doi:10.1001/jamanetworkopen. 2019.7216 · DOI
  30. Volkow ND, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014; 371(9):878-879. doi:10.1056/NEJMc1407928 · DOI
  31. Jager G, Ramsey NF. Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research. Curr Drug Abuse Rev. 2008;1(2):114-123. doi:10.2174/1874473710801020114 · DOI
  32. Hasin DS, Kerridge BT, Saha TD, et al. Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry. 2016;173(6):588-599. doi:10.1176/appi.ajp.2015.15070907 · DOI · Paper page
  33. Meier MH, Caspi A, Cerdá M, et al. Associations between cannabis use and physical health problems in early midlife: a longitudinal comparison of persistent cannabis vs tobacco users. JAMA Psychiatry. 2016;73(7):731-740. doi:10.1001/ jamapsychiatry.2016.0637 · DOI
  34. Estoup AC, Moise-Campbell C, Varma M, Stewart DG. The impact of marijuana legalization on adolescent use, consequences, and perceived risk. Subst Use Misuse. 2016;51(14):1881-1887. doi:10.1080/10826084.2016.1200623 · DOI
  35. Mason WA, Fleming CB, Ringle JL, Hanson K, Gross TJ, Haggerty KP. Prevalence of marijuana and other substance use before and after Washington State's change from legal medical marijuana to legal medical and nonmedical marijuana: Cohort comparisons in a sample of adolescents. Subst Abus. 2016;37(2):330-335. doi:10.1080/08897077.2015. 1071723 · DOI · Paper page
  36. Jones J, Nicole Jones K, Peil J. The impact of the legalization of recreational marijuana on college students. Addict Behav. 2018;77:255-259. doi:10.1016/j.addbeh.2017.08.015 · DOI
  37. Kosterman R, Bailey JA, Guttmannova K, et al. Marijuana legalization and parents' attitudes, use, and parenting in Washington State. J Adolesc Health. 2016;59(4):450-456. doi:10.1016/j.jadohealth.2016. 07.004 · DOI
  38. Pacula RL, Powell D, Heaton P, Sevigny EL. Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J Policy Anal Manage. 2015;34(1):7-31. doi:10.1002/pam. 21804 · DOI
  39. Hayatbakhsh MR, Najman JM, Bor W, O'Callaghan MJ, Williams GM. Multiple risk factor model predicting cannabis use and use disorders: a longitudinal study. Am J Drug Alcohol Abuse. 2009;35(6):399-407. doi:10.3109/ 00952990903353415 · DOI
  40. Budney AJ, Borodovsky JT. The potential impact of cannabis legalization on the development of cannabis use disorders. Prev Med. 2017;104:31-36. doi:10.1016/j.ypmed.2017.06.034 · DOI
  41. Bachman JG, Wadsworth KN, O'Malley PM, Johnston LD, Schulenberg J. Smoking, Drinking, and Drug Use in Young Adulthood: The Impacts of New Freedoms and New Responsibilities. New York, NY: Psychology Press; 2013. doi:10.4324/ 9780203763797 · DOI
  42. Pacula RL, Smart R. Medical marijuana and marijuana legalization. Annu Rev Clin Psychol. 2017; 13:397-419. doi:10.1146/annurev-clinpsy-032816- 045128 · DOI

Cited by

Sorted by citations

Authors
Cerdá, M., Mauro, C., Hamilton, A., Levy, N. S., Santaella-Tenorio, J., Hasin, D., Wall, M. M., Keyes, K. M., & Martins, S. S.
Affiliations
  • New York University (US)
  • Columbia University (US)
  • New York State Psychiatric Institute (US)
Corresponding author
Cerdá, Magdalena
Venue
JAMA Psychiatry
Published
2020-02-01
Volume
77
Issue
2
Pages
165
ISSN
2168-622X (ISSN-L)
OpenAlex
W2986974687
Cited by
598
References
4
Citations by year
2026: 58 · 2025: 92 · 2024: 80 · 2023: 107 · 2022: 107 · 2021: 94 · 2020: 55 · 2019: 4 · 2017: 1
FWCI
40.29
Type
journal article
Language
en
Open access
Locations
  • JAMA Psychiatry (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Drug Abuse (R01DA048860, R01DA037866)
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
recreational cannabis legalization, cannabis use disorder, cannabis use, adolescents, young adults, state policy effects, drug policy, National Survey on Drug Use and Health, confounding
MeSH terms
Marijuana Use, Adolescent, Adult, Marijuana Abuse, Child, Cross-Sectional Studies, Female, Humans, Male, Surveys and Questionnaires, State Government, United States, Logistic Models, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review